Literature DB >> 7981070

Changes in use of breast-conserving therapy in years 1978-2000.

H J de Koning1, J A van Dongen, P J van der Maas.   

Abstract

The treatment of breast cancer patients has changed rapidly in the past decade, but empirical data at local and national level are scarce. Predicting the consequences of screening for primary treatment is consequently difficult. The aim of this analysis of records on admissions to hospital of women with breast cancer and/or for breast surgery (1975-90) together with a survey of all Dutch radiotherapy departments (1986-88) is to show the change in breast-conserving therapy and other primary treatment before the start of breast cancer screening in The Netherlands. There was a modest increase in breast-conserving therapy after 1981, coinciding with the first publication on its trial, followed by a sharp increase between 1985 and 1990, after the second publication. At the end of that 5 year period, 36% of all women with newly diagnosed invasive breast cancer underwent this type of surgery. Breast-conserving surgery is always followed by radiotherapy, but there has been a clear reduction in post-operative radiation after mastectomy. The percentage of breast-conserving therapy is at present higher in The Netherlands than in the USA. Implementing the Dutch screening programme will result in a maximum increase in breast-conserving therapy at national level of 34%, which stabilises at +21%, or a 50% maximum increase at local level. The number of women treated by mastectomy will ultimately decrease by 9%. Given the rapidity of change towards the use of breast-conserving surgery, which is enhanced by screening, recent information will be needed in predicting capacity and assessing whether screen-detected women are treated adequately.

Entities:  

Mesh:

Year:  1994        PMID: 7981070      PMCID: PMC2033702          DOI: 10.1038/bjc.1994.466

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  21 in total

1.  A model-based analysis of the HIP project for breast cancer screening.

Authors:  G J van Oortmarssen; J D Habbema; J T Lubbe; P J van der Maas
Journal:  Int J Cancer       Date:  1990-08-15       Impact factor: 7.396

2.  A model for breast cancer screening.

Authors:  G J van Oortmarssen; J D Habbema; P J van der Maas; H J de Koning; H J Collette; A L Verbeek; A T Geerts; K T Lubbe
Journal:  Cancer       Date:  1990-10-01       Impact factor: 6.860

3.  Put the "hockey stick" on ice.

Authors:  J R Harris; S Hellman
Journal:  Int J Radiat Oncol Biol Phys       Date:  1988-08       Impact factor: 7.038

Review 4.  Does adjuvant radiotherapy have a role in the postmastectomy management of patients with operable breast cancer--revisited.

Authors:  R W Edland
Journal:  Int J Radiat Oncol Biol Phys       Date:  1988-09       Impact factor: 7.038

5.  Changing indications for breast conserving therapy: proportion of patients with operable breast cancer suitable for breast conservation.

Authors:  M J Hooning; J A van Dongen; G Went
Journal:  Neth J Surg       Date:  1991-08

6.  Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors.

Authors:  H J de Koning; B M van Ineveld; G J van Oortmarssen; J C de Haes; H J Collette; J H Hendriks; P J van der Maas
Journal:  Int J Cancer       Date:  1991-10-21       Impact factor: 7.396

7.  Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast.

Authors:  U Veronesi; R Saccozzi; M Del Vecchio; A Banfi; C Clemente; M De Lena; G Gallus; M Greco; A Luini; E Marubini; G Muscolino; F Rilke; B Salvadori; A Zecchini; R Zucali
Journal:  N Engl J Med       Date:  1981-07-02       Impact factor: 91.245

8.  The impact of tumor size and histology on local control after breast-conserving therapy.

Authors:  H Bartelink; J H Borger; J A van Dongen; J L Peterse
Journal:  Radiother Oncol       Date:  1988-04       Impact factor: 6.280

9.  Prediction of the effects and costs of breast-cancer screening in Germany.

Authors:  P M Beemsterboer; H J de Koning; P G Warmerdam; R Boer; E Swart; M L Dierks; B P Robra
Journal:  Int J Cancer       Date:  1994-09-01       Impact factor: 7.396

10.  Breast cancer screening: its impact on clinical medicine.

Authors:  H J de Koning; G J van Oortmarssen; B M van Ineveld; P J van der Maas
Journal:  Br J Cancer       Date:  1990-02       Impact factor: 7.640

View more
  2 in total

1.  Effect of mammography screening on surgical treatment for breast cancer in Norway: comparative analysis of cancer registry data.

Authors:  Pål Suhrke; Jan Mæhlen; Ellen Schlichting; Karsten Juhl Jørgensen; Peter C Gøtzsche; Per-Henrik Zahl
Journal:  BMJ       Date:  2011-09-13

2.  Breast conservation, mastectomy and axillary surgery in New South Wales women in 1992 and 1995.

Authors:  A Kricker; J Haskill; B K Armstrong
Journal:  Br J Cancer       Date:  2001-09-01       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.